Product Information
VARENICLINE 1 MG CONT MONTH BX is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.4185 per EA under NDC 68462089404. Its NADAC has been published 74 times since Jan 29, 2025.
Strength
1 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462089404
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
VARENICLINE TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA214255On Market Since
8/22/2023
Pharmacological Classes
Price Statistics
The NADAC for VARENICLINE 1 MG CONT MONTH BX has been published 74 times since Jan 29, 2025, and over the history we have for it it has declined 29.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4185 per EA |
|---|---|
| All-time high | $0.5970 (Feb 12, 2025) |
| All-time low | $0.4026 (May 20, 2026) |
| 52-week high | $0.5408 |
| 52-week low | $0.4026 |
| Median price | $0.4838 |
| Average price | $0.4883 |
| Largest weekly change | -5.4% (Sep 17, 2025) |
| Weeks tracked | 74 |
| Tracking since | Jan 29, 2025 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of VARENICLINE 1 MG CONT MONTH BX?
The current National Average Drug Acquisition Cost (NADAC) for VARENICLINE 1 MG CONT MONTH BX, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.4185 per EA (NDC 68462089404), effective Jun 24, 2026.
How has the price of VARENICLINE 1 MG CONT MONTH BX changed over time?
Over the history we have for it, the NADAC for VARENICLINE 1 MG CONT MONTH BX has declined 29.9%. It has been tracked across 74 weekly CMS publications since Jan 29, 2025.
What are the highest and lowest recorded NADAC prices for VARENICLINE 1 MG CONT MONTH BX?
Since Jan 29, 2025, the NADAC for VARENICLINE 1 MG CONT MONTH BX has ranged from a low of $0.4026 (May 20, 2026) to a high of $0.5970 (Feb 12, 2025), with a median of $0.4838 per EA.
Are there cheaper alternatives to VARENICLINE 1 MG CONT MONTH BX?
7 NADAC-published products share the same active ingredient, strength, and dosage form as VARENICLINE 1 MG CONT MONTH BX, but none are currently priced below it.
Who manufactures VARENICLINE 1 MG CONT MONTH BX?
VARENICLINE 1 MG CONT MONTH BX (NDC 68462089404) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.
Related Drugs
Same classification